Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Wendys Co (WEN) Price & Performance

AbCellera Biologics IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Wendys Co — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Wendys Co trades at $7.55 (market cap $1.44B). The key difference: AbCellera Biologics Inc is far larger — about 2.1× Wendys Co's market cap, and Wendys Co pays a 3.71% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLWEN
Market Cap
$2.99B$1.44B
Sector
HealthConsumer Cyclical
52-Week High
$9.76$10.68
52-Week Low
$2.78$6.17
Enterprise Value
$2.58B$5.17B
Dividend Yield
3.71%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Wendys Co

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.

Read more on WEN